Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,122 shares at $612.74 ($2.5M) on 2020-06-11, disclosed to the SEC on 2020-06-12.
Open-market sale of $2.5M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $610.18 | 2,512 | $1.5M | 60.9% |
| 2 | $607.50 | 445 | $270K | 10.7% |
| 3 | $607.50 | 445 | $270K | 10.7% |
| 4 | $608.91 | 65 | $40K | 1.6% |
| 5 | $611.82 | 14 | $9K | 0.3% |
| 6 | $612.74 | 177 |
| $108K |
| 4.3% |
| 7 | $612.74 | 177 | $108K | 4.3% |
| 8 | $613.53 | 23 | $14K | 0.6% |
| 9 | $614.41 | 34 | $21K | 0.8% |
| 10 | $616.00 | 31 | $19K | 0.8% |
| 11 | $619.73 | 66 | $41K | 1.6% |
| 12 | $620.70 | 58 | $36K | 1.4% |
| 13 | $621.56 | 16 | $10K | 0.4% |
| 14 | $624.56 | 59 | $37K | 1.5% |
| Total | $610.46 avg | 4,122 | $2.5M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |